LU75901A1 - - Google Patents

Info

Publication number
LU75901A1
LU75901A1 LU75901A LU75901A LU75901A1 LU 75901 A1 LU75901 A1 LU 75901A1 LU 75901 A LU75901 A LU 75901A LU 75901 A LU75901 A LU 75901A LU 75901 A1 LU75901 A1 LU 75901A1
Authority
LU
Luxembourg
Application number
LU75901A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/618,176 external-priority patent/US4004005A/en
Application filed filed Critical
Publication of LU75901A1 publication Critical patent/LU75901A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
LU75901A 1975-09-30 1976-09-28 LU75901A1 (xx)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/618,176 US4004005A (en) 1975-09-30 1975-09-30 Steroidal erythropoietic agents and therapeutic compositions and methods
US05/693,249 US4049805A (en) 1975-09-30 1976-06-04 Steroidal erythropoietic agents and therapeutic compositions and methods

Publications (1)

Publication Number Publication Date
LU75901A1 true LU75901A1 (xx) 1977-05-11

Family

ID=27088168

Family Applications (1)

Application Number Title Priority Date Filing Date
LU75901A LU75901A1 (xx) 1975-09-30 1976-09-28

Country Status (10)

Country Link
US (1) US4049805A (xx)
JP (1) JPS5262263A (xx)
CH (1) CH625253A5 (xx)
DE (1) DE2643936A1 (xx)
DK (1) DK145859C (xx)
FR (1) FR2326198A1 (xx)
GB (1) GB1565229A (xx)
IE (1) IE43859B1 (xx)
LU (1) LU75901A1 (xx)
NL (1) NL7610812A (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE473759T1 (de) 1998-05-22 2010-07-15 Univ Leland Stanford Junior Bifunktionelle moleküle sowie darauf basierende therapien.
US20040265285A1 (en) * 1999-04-15 2004-12-30 Monash University Normalization of defective T cell responsiveness through manipulation of thymic regeneration
AUPR074500A0 (en) * 2000-10-13 2000-11-09 Monash University Treatment of t cell disorders
US20050042679A1 (en) * 1999-04-15 2005-02-24 Monash University Diagnostic indicator of thymic function
US20040259803A1 (en) * 1999-04-15 2004-12-23 Monash University Disease prevention by reactivation of the thymus
US20040241842A1 (en) * 1999-04-15 2004-12-02 Monash University Stimulation of thymus for vaccination development
US20040258672A1 (en) * 1999-04-15 2004-12-23 Monash University Graft acceptance through manipulation of thymic regeneration
US20050020524A1 (en) * 1999-04-15 2005-01-27 Monash University Hematopoietic stem cell gene therapy
US20060088512A1 (en) * 2001-10-15 2006-04-27 Monash University Treatment of T cell disorders
CA2462681A1 (en) * 2000-10-13 2002-04-18 Monash University Disease prevention by reactivation of the thymus
DE60234057D1 (de) 2001-07-25 2009-11-26 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
US20080279812A1 (en) * 2003-12-05 2008-11-13 Norwood Immunology, Ltd. Disease Prevention and Vaccination Prior to Thymic Reactivation
CN103259027A (zh) 2005-04-28 2013-08-21 普罗透斯数字保健公司 药物信息系统
JP2009508494A (ja) 2005-09-16 2009-03-05 ラプトール ファーマシューティカル インコーポレイテッド Crを含むタンパク質に対して特異的な受容体−結合タンパク質(rap)変異体を含む組成物およびその使用
PT2398500T (pt) 2009-02-20 2019-06-14 2 Bbb Medicines B V Sistema de entrega de medicamentos à base de glutationas
TWI556839B (zh) 2009-05-06 2016-11-11 研究室護膚股份有限公司 包含活性劑-磷酸鈣粒子複合物之皮膚遞送組成物及其使用方法

Also Published As

Publication number Publication date
DK145859C (da) 1983-10-03
US4049805A (en) 1977-09-20
JPS5262263A (en) 1977-05-23
NL7610812A (nl) 1977-04-01
GB1565229A (en) 1980-04-16
CH625253A5 (xx) 1981-09-15
IE43859L (en) 1977-03-30
IE43859B1 (en) 1981-06-17
DE2643936A1 (de) 1977-03-31
DK437976A (da) 1977-03-31
FR2326198A1 (fr) 1977-04-29
FR2326198B1 (xx) 1980-10-10
DK145859B (da) 1983-03-21

Similar Documents

Publication Publication Date Title
FR2326198B1 (xx)
JPS5337066B2 (xx)
JPS5413463Y2 (xx)
JPS51130137U (xx)
JPS5239106U (xx)
JPS5248581U (xx)
IN142357B (xx)
JPS51111256U (xx)
JPS5193677A (xx)
JPS5196188U (xx)
JPS5196433A (xx)
JPS5260123U (xx)
CH606895A5 (xx)
CH604367A5 (xx)
BG22152A1 (xx)
BG22483A1 (xx)
BG22493A1 (xx)
BG22115A1 (xx)
CH603773A5 (xx)
BG22696A1 (xx)
BG22748A1 (xx)
CH601792A5 (xx)
BG21624A1 (xx)
BE841787A (xx)
AU480667A (xx)